Respiratory Inhalers Contribute to Greenhouse Gas Emissions, Worsening Climate Change and Respiratory Conditions
Inhalers, commonly used to provide fast-acting treatment for people with asthma and chronic obstructive pulmonary disease (COPD), have been found to contribute to greenhouse gas emissions, exacerbating both climate change and the conditions themselves. According to a recent study published in the Journal of the American Medical Association, inhalers approved for asthma and COPD generated an estimated 24.9 million metric tons of carbon dioxide equivalent emissions in the United States from 2014 to 2024.
This significant amount of emissions is equivalent to the emissions of about 530,000 gas-powered cars each year, highlighting the substantial impact of inhalers on the environment. The study’s findings suggest that the widespread use of inhalers, with tens of millions dispensed annually, drives global warming and worsens the very respiratory conditions they are meant to relieve. As the Asthma and Allergy Foundation of America reports, 28 million Americans have asthma and 34 million have chronic lung disease, with cases expected to grow as climate change makes air pollution worse.
Metered-Dose Inhalers: The Most Harmful to the Environment
Researchers found that metered-dose inhalers, which contain hydrofluoroalkane propellants, were the most harmful to the environment, accounting for 98% of emissions over the decade-long period. These propellants, widely used in products like aerosol sprays, are potent greenhouse gases that contribute significantly to the growing carbon footprint of the US healthcare system. According to Dr. William Feldman, lead author and pulmonologist, “Inhalers add to the growing carbon footprint of the US healthcare system, putting many patients with chronic respiratory disease at risk.”
However, it’s not the medication itself that’s the problem, but rather the propellants used in the inhalers. Fortunately, there are alternative types of inhalers, such as dry inhalers and soft powder mist inhalers, which are less harmful and deliver medication to the lungs without the need for propellants. These lower-emission alternatives offer a tremendous opportunity to make changes that protect both patients and the planet.
Reducing Emissions and Promoting Sustainable Healthcare
The study’s findings emphasize the need for sustainable healthcare practices that minimize harm to the environment while providing effective treatment for patients. By utilizing lower-emission alternatives and reducing the use of metered-dose inhalers, we can mitigate the impact of inhalers on climate change and promote a healthier environment for all. As the authors of the study note, “Scaled across tens of millions of inhalers dispensed annually, these emissions drive global warming, exacerbating the very respiratory conditions inhalers are meant to relieve.” By making informed choices and adopting sustainable practices, we can work towards a healthier future for both people and the planet.
For more information on this study and its findings, visit Here
Image Source: www.cbsnews.com
